{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:06:30Z","timestamp":1786993590268,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jtos.2021.08.017","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:18:35Z","timestamp":1630462715000},"page":"224-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Immune signaling in rosacea"],"prefix":"10.1016","volume":"22","author":[{"given":"Edward J.","family":"Wladis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-7235","authenticated-orcid":false,"given":"Alejandro P.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2021.08.017_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2009.03132.x","article-title":"Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin","volume":"23","author":"Bakar","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jtos.2021.08.017_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00003226-200304000-00009","article-title":"The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics","volume":"22","author":"Ghanem","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.08.017_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0974-9233.63070","article-title":"Spontaneous corneal perforation in ocular rosacea","volume":"17","author":"Al Arfaj","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2012.11037.x","article-title":"A study on the epidemiology of rosacea in the U.K","volume":"167","author":"Spoendlin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13555-016-0106-9","article-title":"Erythema of rosacea impairs health-related quality of life: results of a meta-analysis","volume":"6","author":"Bewley","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jtos.2021.08.017_bib7","first-page":"120","article-title":"Results of a national rosacea patient survey: common issues that concern rosacea sufferers","volume":"8","author":"Elewski","year":"2009","journal-title":"J Drugs Dermatol JDD : J Drugs Dermatol JDD"},{"key":"10.1016\/j.jtos.2021.08.017_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-015-0077-2","article-title":"Perceptions on the psychological impact of facial erythema associated with rosacea: results of international survey","volume":"5","author":"Dirschka","year":"2015","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jtos.2021.08.017_bib9","first-page":"348","article-title":"Burden of disease: the psychosocial impact of rosacea on a patient's quality of life","volume":"6","author":"Huynh","year":"2013","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.jtos.2021.08.017_bib10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaad.2016.12.043","article-title":"The burden of skin disease in the United States","volume":"76","author":"Lim","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib11","article-title":"Treatment of ocular rosacea","author":"Wladis","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.fsc.2012.11.004","article-title":"Rosacea: pathophysiology and management principles","volume":"21","author":"Chauhan","year":"2013","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.jtos.2021.08.017_bib13","first-page":"31","article-title":"A guide to the ingredients and potential benefits of over-the-counter cleansers and moisturizers for rosacea patients","volume":"4","author":"Levin","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ophtha.2015.10.062","article-title":"Oral antibiotics for meibomian gland-related ocular surface disease: a report by the American Academy of ophthalmology","volume":"123","author":"Wladis","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.08.017_bib15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e3181d836f3","article-title":"Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction","volume":"29","author":"Maskin","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.08.017_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/IOP.0b013e3182627ebc","article-title":"Intraductal meibomian gland probing in the management of ocular rosacea","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2021.08.017_bib17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/OPTH.S109663","article-title":"The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye","volume":"10","author":"Blackie","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2020.03.009","article-title":"Intense pulsed light for meibomian gland disease: a report by the American Academy of ophthalmology","volume":"127","author":"Wladis","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.08.017_bib19","first-page":"2506","article-title":"Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea","volume":"40","author":"Afonso","year":"1999","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1016\/j.jtos.2021.08.017_bib20","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","article-title":"Inflammatory cytokines in the tears of patients with ocular rosacea","volume":"104","author":"Barton","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.08.017_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/IOP.0b013e31824dd9d4","article-title":"Molecular biologic assessment of cutaneous specimens of ocular rosacea","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2021.08.017_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"10.1016\/j.jtos.2021.08.017_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ni.2680","article-title":"The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells","volume":"14","author":"Heath","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000249558","article-title":"T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum","volume":"169","author":"Rufli","year":"1984","journal-title":"Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib26","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/IOP.0b013e3182565c59","article-title":"Toll-like receptors in idiopathic orbital inflammation","volume":"28","author":"Wladis","year":"2012","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jtos.2021.08.017_bib29","first-page":"420","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1530-0277.2009.01065.x","article-title":"Alcohol up-regulates TLR2 through a NO\/cGMP dependent pathway","volume":"34","author":"Bailey","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jtos.2021.08.017_bib31","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/acer.12803","article-title":"TLR2 and TLR4 expression and inflammatory cytokines are altered in the airway epithelium of those with alcohol use disorders","volume":"39","author":"Bailey","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jtos.2021.08.017_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/exd.12477","article-title":"Toll-like receptor 2 mediates a cutaneous reaction induced by repetitive ultraviolet B irradiation in C57\/BL6 mice in vivo","volume":"23","author":"Park","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib33","doi-asserted-by":"crossref","first-page":"30033","DOI":"10.1074\/jbc.274.42.30033","article-title":"Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation","volume":"274","author":"Brattsand","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2021.08.017_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jtos.2021.08.017_bib35","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"Durr","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtos.2021.08.017_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-0625.2008.00768.x","article-title":"The vitamin D pathway: a new target for control of the skin's immune response?","volume":"17","author":"Schauber","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.0022-202X.2004.23443.x","article-title":"Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies","volume":"124","author":"Braff","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamem.2015.11.003","article-title":"The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator","volume":"1858","author":"Xhindoli","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtos.2021.08.017_bib40","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.4049\/jimmunol.170.5.2274","article-title":"Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide","volume":"170","author":"Di Nardo","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib41","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib42","first-page":"7357162","article-title":"Cathelicidin LL-37 affects surface and intracellular toll-like receptor expression in tissue mast cells","author":"Agier","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtos.2021.08.017_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jid.2019.08.436","article-title":"Innate immune dysfunction in rosacea promotes photosensitivity and vascular adhesion molecule expression","volume":"140","author":"Kulkarni","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib44","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fimmu.2020.00976","article-title":"CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond","volume":"11","author":"Karin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib45","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/exd.13133","article-title":"Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin","volume":"25","author":"Lee","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-017-0176-3","article-title":"Topical treatment of rosacea with ivermectin inhibits gene expression of cathelicidin innate immune mediators, LL-37 and KLK5, in reconstructed and ex vivo skin models","author":"Thibaut de Menonville","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jtos.2021.08.017_bib47","first-page":"39","article-title":"Topical ivermectin: data supporting dual modes of action in rosacea","volume":"10","author":"Del Rosso","year":"2017","journal-title":"The Journal of clinical and aesthetic dermatology"},{"key":"10.1016\/j.jtos.2021.08.017_bib48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1167\/iovs.16-20275","article-title":"Activation of p38 and Erk mitogen-activated protein kinases signaling in ocular rosacea","volume":"58","author":"Wladis","year":"2017","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1016\/j.jtos.2021.08.017_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2008.04.024","article-title":"Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway","volume":"588","author":"Tsai","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jtos.2021.08.017_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.dci.2017.03.017","article-title":"Lipopolysaccharide induced Interleukin-6 production is mediated through activation of ERK 1\/2, p38 MAPK, MEK, and NFkappaB in chicken thrombocytes","volume":"73","author":"Winkler","year":"2017","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib51","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","article-title":"NF-kappaB and the immune response","volume":"25","author":"Hayden","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jtos.2021.08.017_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-0765.2012.01524.x","article-title":"Antimicrobial peptide LL37 promotes vascular endothelial growth factor-A expression in human periodontal ligament cells","volume":"48","author":"Kittaka","year":"2013","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.jtos.2021.08.017_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12703\/P6-97","article-title":"MyD88: a central player in innate immune signaling","volume":"6","author":"Deguine","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.jtos.2021.08.017_bib54","article-title":"Nuclear factor kappa-B is enriched in eyelid specimens of rosacea: implications for pathogenesis and therapy","author":"Wladis","year":"2019","journal-title":"AJO (Am J Ophthalmol)"},{"key":"10.1016\/j.jtos.2021.08.017_bib55","first-page":"1","article-title":"Myeloid differentiation factor 88 expression in eyelid specimens of rosacea","author":"Wladis","year":"2021","journal-title":"Orbit"},{"key":"10.1016\/j.jtos.2021.08.017_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202323","article-title":"TLR4-mediated activation of the ERK pathway following UVA irradiation contributes to increased cytokine and MMP expression in senescent human dermal fibroblasts","volume":"13","author":"Seo","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.08.017_bib57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/jid.2008.261","article-title":"Myeloid differentiation factor 88 regulates basal and UV-induced expressions of IL-6 and MMP-1 in human epidermal keratinocytes","volume":"129","author":"Lee","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41418-018-0159-7","article-title":"Innate immune adaptor MyD88 deficiency prevents skin inflammation in SHARPIN-deficient mice","volume":"26","author":"Sharma","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jtos.2021.08.017_bib59","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1167\/iovs.17-23397","article-title":"MyD88 deficiency protects against dry eye-induced damage","volume":"59","author":"Reins","year":"2018","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1016\/j.jtos.2021.08.017_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/alcalc\/agw098","article-title":"The role of NFkB in drug addiction: beyond inflammation","volume":"52","author":"Nennig","year":"2017","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jtos.2021.08.017_bib61","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1751-1097.2010.00767.x","article-title":"Differential signaling circuits in regulation of ultraviolet C light-induced early- and late-phase activation of NF-kappaB","volume":"86","author":"Wu","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jtos.2021.08.017_bib62","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/carcin\/23.9.1511","article-title":"Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2","volume":"23","author":"Anto","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtos.2021.08.017_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00403-009-0994-y","article-title":"The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways","volume":"302","author":"Muthusamy","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jtos.2021.08.017_bib64","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.lfs.2003.11.001","article-title":"MAP kinase signaling in diverse effects of ethanol","volume":"74","author":"Aroor","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jtos.2021.08.017_bib65","doi-asserted-by":"crossref","first-page":"107013","DOI":"10.1016\/j.intimp.2020.107013","article-title":"Molecular insights of cigarette smoke condensate-activated NLRP3 inflammasome in THP-1 cells in a stage-specific atherogenesis","volume":"88","author":"Mehta","year":"2020","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.jtos.2021.08.017_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.det.2017.11.002","article-title":"Genetic predisposition to rosacea","volume":"36","author":"Awosika","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jtos.2021.08.017_bib67","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","article-title":"Evidence-based update on rosacea comorbidities and their common physiologic pathways","volume":"78","author":"Holmes","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib68","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","article-title":"Risk factors associated with rosacea","volume":"24","author":"Abram","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jtos.2021.08.017_bib69","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2015.07.009","article-title":"Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study","volume":"73","author":"Rainer","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib70","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/jdv.12234","article-title":"Rosacea and cardiovascular risk factors: a case control study","volume":"28","author":"Duman","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jtos.2021.08.017_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2015.11.004","article-title":"Clustering of autoimmune diseases in patients with rosacea","volume":"74","author":"Egeberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib72","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","article-title":"Rosacea in patients with ulcerative colitis and crohn's disease: a population-based case-control study","volume":"22","author":"Spoendlin","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jtos.2021.08.017_bib73","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/jid.2013.225","article-title":"Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs","volume":"133","author":"Spoendlin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib74","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2015.2230","article-title":"Genetic vs environmental factors that correlate with rosacea A cohort-based survey of twins","volume":"151","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy184","article-title":"Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes","author":"Aponte","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtos.2021.08.017_bib76","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jid.2019.09.021","article-title":"Alterations of immune and keratinization gene expression in papulopustular rosacea by whole transcriptome analysis","volume":"140","author":"Shih","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib77","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jid.2016.12.025","article-title":"Sebaceous gland-rich skin is characterized by TSLP expression and distinct immune surveillance which is disturbed in rosacea","volume":"137","author":"Dajnoki","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib78","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/bjd.19172","article-title":"An exploratory, open-label, investigator-initiated study of interleukin-17 blockade in patients with moderate-to-severe papulopustular rosacea","volume":"183","author":"Kumar","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.survophthal.2014.10.001","article-title":"Retinoic acid and the ocular surface","volume":"60","author":"Samarawickrama","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib80","first-page":"CD003262","article-title":"Interventions for rosacea","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtos.2021.08.017_bib81","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jtos.2021.08.017_bib82","first-page":"54","article-title":"Use of oral isotretinoin in the management of rosacea","volume":"4","author":"Park","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib83","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Investigative ophthalmology & visual science."},{"key":"10.1016\/j.jtos.2021.08.017_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000267402","article-title":"Toxic effects of systemic retinoids on meibomian glands","volume":"26","author":"Kremer","year":"1994","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2021.08.017_bib85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0420.1995.tb00043.x","article-title":"Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora","volume":"73","author":"Egger","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jtos.2021.08.017_bib86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/112067210901900204","article-title":"Comparison of dose-related ocular side effects during systemic isotretinoin administration","volume":"19","author":"Cumurcu","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5935\/0004-2749.20200016","article-title":"Ocular surface changes in the treatment of rosacea: comparison between low-dose oral isotretinoin and doxycycline","volume":"83","author":"Andrade","year":"2020","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib88","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.jid.5700418","article-title":"Isotretinoin revisited: pluripotent effects on human sebaceous gland cells","volume":"126","author":"Zouboulis","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2021.08.017_bib89","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1167\/iovs.13-11863","article-title":"The influence of 13-cis retinoic acid on human meibomian gland epithelial cells","volume":"54","author":"Ding","year":"2013","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1016\/j.jtos.2021.08.017_bib90","doi-asserted-by":"crossref","first-page":"17060","DOI":"10.1074\/jbc.RA119.010835","article-title":"Mice lacking the epidermal retinol dehydrogenases SDR16C5 and SDR16C6 display accelerated hair growth and enlarged meibomian glands","volume":"294","author":"Wu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtos.2021.08.017_bib91","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtos.2021.08.017_bib92","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in psoriasis and beyond: cardiovascular and metabolic implications","volume":"10","author":"von Stebut","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib93","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jtos.2021.08.017_bib94","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.coph.2012.06.002","article-title":"New developments in Toll-like receptor targeted therapeutics","volume":"12","author":"Connolly","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jtos.2021.08.017_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.08.010","article-title":"Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management","volume":"239","author":"Gambuzza","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtos.2021.08.017_bib96","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","article-title":"Targeting Toll-like receptors: emerging therapeutics?","volume":"9","author":"Hennessy","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtos.2021.08.017_bib97","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1517\/13543780903321490","article-title":"The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer","volume":"18","author":"Yong","year":"2009","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.jtos.2021.08.017_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of alzheimer's disease","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jtos.2021.08.017_bib99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ccr.2014.07.027","article-title":"Cancer-selective targeting of the NF-kappaB survival pathway with GADD45beta\/MKK7 inhibitors","volume":"26","author":"Tornatore","year":"2014","journal-title":"Canc Cell"},{"key":"10.1016\/j.jtos.2021.08.017_bib100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1087057115617456","article-title":"Modulation of NF-kappaB signaling as a therapeutic target in autoimmunity","volume":"21","author":"Herrington","year":"2016","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.jtos.2021.08.017_bib101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.12.020","article-title":"Ex-vivo generation of drug-eluting islets improves transplant outcomes by inhibiting TLR4-Mediated NFkB upregulation","volume":"159","author":"Chang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtos.2021.08.017_bib102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jep.2016.01.010","article-title":"Improvement of atopic dermatitis with topical application of Spirodela polyrhiza","volume":"180","author":"Lee","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jtos.2021.08.017_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136777","article-title":"In vitro and in vivo studies on protective action of N-phenethyl caffeamide against photodamage of skin","volume":"10","author":"Kuo","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.08.017_bib104","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","article-title":"Ibrutinib in previously treated Waldenstrom's macroglobulinemia","volume":"372","author":"Treon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2021.08.017_bib105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B Cell receptor signaling by ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Canc Cell"},{"key":"10.1016\/j.jtos.2021.08.017_bib106","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41375-019-0661-z","article-title":"CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88\/NF-kappaB signaling","volume":"34","author":"Jin","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtos.2021.08.017_bib107","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1159\/000490866","article-title":"Effects of the TLR4\/myd88\/NF-kappaB signaling pathway on NLRP3 inflammasome in coronary microembolization-induced myocardial injury","volume":"47","author":"Su","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jtos.2021.08.017_bib108","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1159\/000494745","article-title":"A novel inhibitor of homodimerization targeting MyD88 ameliorates renal interstitial fibrosis by counteracting TGF-beta1-induced EMT in vivo and in vitro","volume":"43","author":"Liu","year":"2018","journal-title":"Kidney Blood Press Res"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:56Z","timestamp":1761540356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":108,"alternative-id":["S1542012421000999"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.08.017","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune signaling in rosacea","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}